β-amyloid dynamics in human plasma
- PMID: 23229043
- PMCID: PMC3808092
- DOI: 10.1001/archneurol.2012.18107
β-amyloid dynamics in human plasma
Abstract
Objectives: To investigate dynamic changes in human plasma β-amyloid (Aβ) concentrations, evaluate the effects of aging and amyloidosis on these dynamics, and determine their correlation with cerebrospinal fluid (CSF) Aβ concentrations.
Design: A repeated plasma and CSF sampling study.
Setting: The Washington University School of Medicine in St Louis, Missouri.
Participants: Older adults with amyloid deposition (Amyloid+), age-matched controls without amyloid deposition (Amyloid-), and younger normal controls (YNCs) were enrolled for the study.
Main outcome measures: Hourly measurements of plasma Aβ were compared between groups by age and amyloidosis. Plasma Aβ and CSF Aβ concentrations were compared for correlation, linear increase, and circadian patterns.
Results: Circadian patterns were observed in plasma Aβ, with diminished amplitudes with aging. Linear increase of Aβ was only observed for CSF Aβ in the YNC and Amyloid- groups, but not in the Amyloid+ group. No linear increase was observed for plasma Aβ. No significant correlations were found between plasma and CSF Aβ concentrations.
Conclusions: Plasma Aβ, like CSF, demonstrates a circadian pattern that is reduced in amplitude with increasing age but is unaffected by amyloid deposition. However, we found no evidence that plasma and CSF Aβ concentrations were related on an hourly or individual basis.
Figures
References
-
- Aronson MK, Ooi WL, Geva DL, Masur D, Blau A, Frishman W. Dementia. Age-dependent incidence, prevalence, and mortality in the old old. Arch Intern Med. 1991 May;151(5):989–992. - PubMed
-
- Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002 Jul 19;297(5580):353–356. - PubMed
-
- Motter R, Vigo-Pelfrey C, Kholodenko D, et al. Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol. 1995 Oct;38(4):643–648. - PubMed
-
- Galasko D, Chang L, Motter R, et al. High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch Neurol. 1998 Jul;55(7):937–945. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P50 AG05681-22/AG/NIA NIH HHS/United States
- R-01-NS065667/NS/NINDS NIH HHS/United States
- R01 NS065667/NS/NINDS NIH HHS/United States
- P01 AG026276/AG/NIA NIH HHS/United States
- UL1 RR024992/RR/NCRR NIH HHS/United States
- UL1 TR000448/TR/NCATS NIH HHS/United States
- P01 AG03991-22/AG/NIA NIH HHS/United States
- K23 AG 03094601/AG/NIA NIH HHS/United States
- P01 AG003991/AG/NIA NIH HHS/United States
- P50 AG005681/AG/NIA NIH HHS/United States
- K08 AG027091-01/AG/NIA NIH HHS/United States
- K23 AG030946/AG/NIA NIH HHS/United States
- KL2 RR024994/RR/NCRR NIH HHS/United States
- K08 AG027091/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
